These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37480566)

  • 1. A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins.
    Guichard A; Lu S; Kanca O; Bressan D; Huang Y; Ma M; Sanz Juste S; Andrews JC; Jay KL; Sneider M; Schwartz R; Huang MC; Bei D; Pan H; Ma L; Lin WW; Auradkar A; Bhagwat P; Park S; Wan KH; Ohsako T; Takano-Shimizu T; Celniker SE; Wangler MF; Yamamoto S; Bellen HJ; Bier E
    Cell Rep; 2023 Aug; 42(8):112842. PubMed ID: 37480566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Arginylation Is Regulated during SARS-CoV-2 Infection.
    Macedo-da-Silva J; Rosa-Fernandes L; Gomes VM; Santiago VF; Santos DM; Molnar CMS; Barboza BR; de Souza EE; Marques RF; Boscardin SB; Durigon EL; Marinho CRF; Wrenger C; Marie SKN; Palmisano G
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
    Davies JP; Almasy KM; McDonald EF; Plate L
    ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes.
    Liu J; Wu S; Zhang Y; Wang C; Liu S; Wan J; Yang L
    Stem Cell Res Ther; 2023 Sep; 14(1):249. PubMed ID: 37705046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
    Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
    mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
    Courouble VV; Dey SK; Yadav R; Timm J; Harrison JJEK; Ruiz FX; Arnold E; Griffin PR
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1618-1630. PubMed ID: 34121407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment.
    Zhu JY; Lee JG; van de Leemput J; Lee H; Han Z
    Cell Biosci; 2021 Mar; 11(1):59. PubMed ID: 33766136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
    Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Wang P; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
    Nat Biotechnol; 2023 Jan; 41(1):128-139. PubMed ID: 36217030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2.
    van de Leemput J; Han Z
    Cell Biosci; 2021 Jun; 11(1):110. PubMed ID: 34120640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies.
    Davies JP; Almasy KM; McDonald EF; Plate L
    bioRxiv; 2020 Jul; ():. PubMed ID: 32699849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
    Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
    Elife; 2022 Nov; 11():. PubMed ID: 36416537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Novel COVID-19 nsp8 One-Tube RT-LAMP-CRISPR Assay for SARS-CoV-2 Diagnosis.
    Yip CC; Sridhar S; Chan WM; Ip JD; Chu AW; Leung KH; Cheng VC; Yuen KY; To KK
    Microbiol Spectr; 2022 Dec; 10(6):e0196222. PubMed ID: 36445095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes.
    Nawaz R; Arif MA; Ahmad Z; Ahad A; Shahid M; Hassan Z; Husnain A; Aslam A; Raza MS; Mehmood U; Idrees M
    BMC Infect Dis; 2023 Dec; 23(1):872. PubMed ID: 38087193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
    van de Leemput J; Han Z
    Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.
    May DG; Martin-Sancho L; Anschau V; Liu S; Chrisopulos RJ; Scott KL; Halfmann CT; Díaz Peña R; Pratt D; Campos AR; Roux KJ
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
    Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
    J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.